<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> are a group of <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> acquired and clonal disorders that are characterized by the intramedullar, abnormal <z:hpo ids='HP_0011420'>death</z:hpo> of myeloid progenitors leading to peripheral variable cytopenias </plain></SENT>
<SENT sid="1" pm="."><plain>Progressive, aregenerative <z:hpo ids='HP_0001903'>anemia</z:hpo> irresponsive to <z:chebi fb="13" ids="33611">B12</z:chebi>, <z:chebi fb="3" ids="37445">folates</z:chebi> or iron supplementation often constitutes the initial complaint </plain></SENT>
<SENT sid="2" pm="."><plain>The diagnosis that may be difficut relies to a careful analysis of bone marrow aspirate <z:mp ids='MP_0000002'>morphology</z:mp> Classification system is based on cytogenetic abnormalities, and both the number of lineage involved, and bone marrow blasts </plain></SENT>
<SENT sid="3" pm="."><plain>It is predictive for the risk of transformation in secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
</text></document>